{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:19:59Z","timestamp":1789712399769,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014438","name":"Business Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejps.2025.107104","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T06:32:25Z","timestamp":1744871545000},"page":"107104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["In vitro biophysical and biological profiling of commercial lipid-based dry eye products"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1146-9886","authenticated-orcid":false,"given":"Janika","family":"J\u00e4ntti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomo","family":"Viitaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Sev\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Moilanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatu","family":"Lajunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Pajula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip. S.","family":"Ekholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Ruponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107104_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics13020207","article-title":"Formulation considerations for the management of dry eye disease","volume":"13","author":"Agarwal","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107104_bib0002","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12325-010-0070-1","article-title":"Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells","volume":"27","author":"Ammar","year":"2010","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejps.2025.107104_bib0003","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12325-011-0029-x","article-title":"Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells","volume":"28","author":"Ammar","year":"2011","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejps.2025.107104_bib0004","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/bjo.86.2.181","article-title":"Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye","volume":"86","author":"Aragona","year":"2002","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ejps.2025.107104_bib60","first-page":"614","article-title":"An SV40-immortalized human corneal epithelial cell line and its characterization","volume":"36","author":"Araki-Sasaki","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2025.107104_bib0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physrev.00002.2012","article-title":"Role of phospholipids in endocytosis, phagocytosis, and macropinocytosis","volume":"93","author":"Bohdanowicz","year":"2013","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.ejps.2025.107104_bib61","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/ICL.0b013e318193f4fc","article-title":"Factors affecting evaporation rates of tear film components measured in vitro","volume":"35","author":"Borchman","year":"2009","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ejps.2025.107104_bib64","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejps.2025.107104_bib62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cis.2013.03.007","article-title":"Water-evaporation reduction by duplex films: application to the human tear film","volume":"197-198","author":"Cerretani","year":"2013","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1016\/j.ejps.2025.107104_bib0009","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1442-9071.2004.00782.x","article-title":"Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro","volume":"32","author":"Cha","year":"2004","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejps.2025.107104_bib0010","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","article-title":"TFOS DEWS II report Executive summary","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejps.2025.107104_bib0012","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jphp.12075","article-title":"Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery","volume":"66","author":"Daull","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107104_bib0011","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/jop.2015.0054","article-title":"Comparison of the anti-inflammatory effects of artificial tears in a rat model of corneal scraping","volume":"32","author":"Daull","year":"2016","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2025.107104_bib63","unstructured":"Desodrop product information, 2024. accessed 12 May 2024. https:\/\/www.bausch.fi\/meidaen-tuotteet\/desodrop\/."},{"key":"10.1016\/j.ejps.2025.107104_bib0013","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/jop.2008.0098","article-title":"Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells","volume":"25","author":"Epstein","year":"2009","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2025.107104_bib0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/17434440.2018.1435271","article-title":"The tear turnover and tear clearance tests \u2013 a review","volume":"15","author":"Garaszczuk","year":"2018","journal-title":"Expert Rev. Med. Devices"},{"key":"10.1016\/j.ejps.2025.107104_bib0017","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1167\/iovs.12-9907","article-title":"Surface chemistry study of the interactions of pharmaceutical ingredients with Human meibum films","volume":"53","author":"Georgiev","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2025.107104_bib0016","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3390\/ijms18071558","article-title":"Surface chemistry interactions of cationorm with films by Human meibum and tear film compounds","volume":"18","author":"Georgiev","year":"2017","journal-title":"IJMS"},{"key":"10.1016\/j.ejps.2025.107104_bib0018","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3390\/ijms18071558","article-title":"Surface chemistry interactions of cationorm with films by Human meibum and tear film compounds","volume":"18","author":"Georgiev","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2025.107104_bib0019","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jtos.2017.05.004","article-title":"TFOS DEWS II iatrogenic report","volume":"15","author":"Gomes","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejps.2025.107104_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2020.102342","article-title":"Strategies to prolong the residence time of drug delivery systems on ocular surface","volume":"288","author":"Grassiri","year":"2021","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2025.107104_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279977","article-title":"The influence of a mineral oil cationic nanoemulsion or perfluorohexyloctane on the tear film lipid layer and higher order aberrations","volume":"18","author":"Habbe","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2025.107104_bib0022","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2016.06.135","article-title":"Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells","volume":"511","author":"Hakkarainen","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107104_bib0023","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1021\/acsptsci.3c00147","article-title":"Early-stage development of an anti-evaporative liposomal formulation for the potential treatment of dry eyes","volume":"6","author":"J\u00e4ntti","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejps.2025.107104_bib0024","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejps.2025.107104_bib0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.exer.2014.01.006","article-title":"Cationorm shows good tolerability on human HCE-2 corneal epithelial cell cultures","volume":"120","author":"Kinnunen","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejps.2025.107104_bib0026","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.3390\/ijms23052434","article-title":"Artificial tears: biological role of their ingredients in the management of dry eye disease","volume":"23","author":"Labetoulle","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.ejps.2025.107104_bib0027","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/aos.14252","article-title":"Disease aetiology-based design of multifunctional microemulsion eye drops for moderate or severe dry eye: a randomized, quadruple-masked and active-controlled clinical trial","volume":"98","author":"Laihia","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ejps.2025.107104_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/604204","article-title":"Successfully improving ocular drug delivery using the cationic nanoemulsion, Novasorb","volume":"2012","author":"Lallemand","year":"2012","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107104_bib0029","doi-asserted-by":"crossref","DOI":"10.1097\/OPX.0b013e31826f32e0","article-title":"Lipid-containing lubricants for dry eye: a systematic review","volume":"89","author":"Lee","year":"2012","journal-title":"Optometry Vis. Sci."},{"key":"10.1016\/j.ejps.2025.107104_bib0030","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.clae.2010.06.010","article-title":"Nonclinical safety evaluation of boric acid and a novel borate-buffered contact lens multi-purpose solution, BiotrueTM multi-purpose solution","volume":"33","author":"Lehmann","year":"2010","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.ejps.2025.107104_bib0031","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/ICO.0b013e318225415a","article-title":"Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study","volume":"31","author":"Lemp","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.ejps.2025.107104_bib0032","first-page":"204","article-title":"Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbits","volume":"14","author":"Liang","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ejps.2025.107104_bib0033","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/bjo.2008.156828","article-title":"Turnover rate of tear-film lipid layer determined by fluorophotometry","volume":"93","author":"Mochizuki","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2025.107104_bib0035","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jtos.2020.06.001","article-title":"Interactions of polar lipids with cholesteryl ester multilayers elucidate tear film lipid layer structure","volume":"18","author":"Paananen","year":"2020","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejps.2025.107104_bib0036","first-page":"1189","article-title":"The preservative polyquaternium-1 increases cytoxicity and NFkappaB linked inflammation in human corneal epithelial cells","volume":"18","author":"Paimela","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ejps.2025.107104_bib0037","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/OPX.0b013e3181824de3","article-title":"Precorneal residence time of artificial tears measured in dry eye subjects","volume":"85","author":"Paugh","year":"2008","journal-title":"Optometry Vis. Sci."},{"key":"10.1016\/j.ejps.2025.107104_bib0039","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/jop.2018.0031","article-title":"Preclinical evaluation of a new hydroxypropyl-guar phospholipid nanoemulsion-based artificial tear formulation in models of corneal epithelium","volume":"35","author":"Rangarajan","year":"2019","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2025.107104_bib0040","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1167\/iovs.12-10487","article-title":"Do lipids retard the evaporation of the tear fluid?","volume":"53","author":"Rantam\u00e4ki","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2025.107104_bib0041","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejpb.2023.03.007","article-title":"Influence of BAKs on tear film lipid layer: in vitro and in silico models","volume":"186","author":"Riedlov\u00e1","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107104_bib0042","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1023\/A:1011956327987","article-title":"Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line","volume":"15","author":"Saarinen-Savolainen","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107104_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120873","article-title":"Colloidal nanosystems with mucoadhesive properties designed for ocular topical delivery","volume":"606","author":"Silva","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107104_bib0044","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.2147\/OPTH.S263362","article-title":"Symptom relief following a single dose of propylene glycol-hydroxypropyl guar nanoemulsion in patients with dry eye disease: a phase IV, multicenter trial","volume":"14","author":"Silverstein","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ejps.2025.107104_bib0045","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00003226-199207000-00003","article-title":"Ocular surface residence times of artificial tear solutions","volume":"4","author":"Snibson","year":"1992","journal-title":"Cornea"},{"key":"10.1016\/j.ejps.2025.107104_bib0046","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.2147\/OPTH.S377960","article-title":"Propylene glycol and hydroxypropyl guar nanoemulsion - safe and effective lubricant eye drops in the management of dry eye disease","volume":"16","author":"Srinivasan","year":"2022","journal-title":"OPTH"},{"key":"10.1016\/j.ejps.2025.107104_bib0047","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1089\/jop.2017.0042","article-title":"Semifluorinated alkane eye drops for treatment of dry eye disease due to Meibomian gland disease","volume":"33","author":"Steven","year":"2017","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2025.107104_bib0049","article-title":"On the effect of liquid crystal orientation in the lipid layer on tear film thinning and breakup","author":"Taranchuk","year":"2024","journal-title":"ArXivOrg"},{"key":"10.1016\/j.ejps.2025.107104_bib0051","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1167\/tvst.13.10.31","article-title":"Hyaluronate protects from benzalkonium chloride-induced ocular surface toxicity","volume":"13","author":"Vereertbrugghen","year":"2024","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107104_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2024.102257","article-title":"Classification of dry eye disease subtypes","volume":"47","author":"Vidal-Rohr","year":"2024","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.ejps.2025.107104_bib0053","doi-asserted-by":"crossref","first-page":"7676","DOI":"10.1021\/acs.nanolett.1c02475","article-title":"Tear film lipid layer structure: self-assembly of O-acyl-\u03c9-hydroxy fatty acids and wax esters into evaporation-resistant monolayers","volume":"21","author":"Viitaja","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejps.2025.107104_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112429","article-title":"On the importance of chain branching in tear film lipid layer wax and cholesteryl esters","volume":"214","author":"Viitaja","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejps.2025.107104_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113145","article-title":"Biophysical profiling of synthetic ultra-long tear film lipids","volume":"223","author":"Viitaja","year":"2023","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejps.2025.107104_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2023.100704","article-title":"In vitro inhibition of evaporation with perfluorohexyloctane, an eye drop for dry eye disease","volume":"98","author":"Vittitow","year":"2023","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.ejps.2025.107104_bib0057","first-page":"8445","article-title":"Role of endogenous ingredients in meibum and film structures on stability of the tear film lipid layer against lateral compression","volume":"35","author":"Yoshida","year":"2019","journal-title":"Langmuir"},{"key":"10.1016\/j.ejps.2025.107104_bib0058","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s40265-024-02016-5","article-title":"Perfluorohexyloctane ophthalmic solution: a review in dry eye disease","volume":"84","author":"Zhuang-Yan","year":"2024","journal-title":"Drugs"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725001034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725001034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:09:42Z","timestamp":1760227782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725001034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":55,"alternative-id":["S0928098725001034"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107104","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro biophysical and biological profiling of commercial lipid-based dry eye products","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107104"}}